Judges Scientific (LON:JDG) Announces Quarterly Earnings Results

Posted by Brenda Bartman on Sep 24th, 2026

Judges Scientific (LON:JDG – Get Free Report) released its quarterly earnings results on Wednesday. The company reported GBX 39 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Judges Scientific had a return on equity of 6.24% and a net margin of 3.77%.

Judges Scientific Stock Performance

Shares of LON:JDG traded down GBX 20 during mid-day trading on Thursday, reaching GBX 3,700. 84,117 shares of the company traded hands, compared to its average volume of 20,556. The company’s 50 day moving average price is GBX 4,175.68 and its 200-day moving average price is GBX 4,380.09. The firm has a market cap of £246.46 million, a PE ratio of 45.45, a PEG ratio of 0.56 and a beta of 0.69. Judges Scientific has a 52 week low of GBX 3,480 and a 52 week high of GBX 6,380. The company has a debt-to-equity ratio of 77.90, a current ratio of 2.39 and a quick ratio of 0.65.

Judges Scientific News Summary

Here are the key news stories impacting Judges Scientific this week:

Positive Sentiment: Management maintained its full-year guidance despite difficult trading conditions, suggesting it expects orders and profitability to improve during the second half. Judges Scientific H1 Revenue Falls 21% to £55.7 Million, Maintains Full-Year Guidance
Positive Sentiment: Judges Scientific raised its interim dividend, signaling continued confidence in cash generation and shareholder returns despite the first-half loss. Judges Scientific H1 Slips Into Loss; Raises Interim Dividend
Positive Sentiment: Berenberg reaffirmed its “buy” rating and set a GBX 5,600 price target, implying analysts see meaningful upside from recent trading levels. Judges Scientific Buy Rating Reaffirmed
Neutral Sentiment: At its H1 earnings call, management discussed the challenging research-funding environment and the outlook for recovery, with investors likely focused on the timing of a return to growth. Judges Scientific H1 2026 Earnings Call Transcript
Negative Sentiment: First-half revenue fell 21% to £55.7 million, while the company posted a loss of 19.5 pence per share. The deterioration increases execution risk and makes the full-year outlook dependent on a stronger second half. Judges Scientific H1 Revenue and Loss
Negative Sentiment: U.S. research-budget cuts have delayed customer purchases and continued to weigh on operating performance, according to coverage of the results. Judges Scientific Continues to Struggle Due to US Research Cuts
Negative Sentiment: The stock moved below its 200-day moving average, a potentially bearish technical signal that may reinforce selling pressure while fundamentals remain weak. Judges Scientific Share Price Passes Below 200-Day Moving Average

Analysts Set New Price Targets

JDG has been the topic of a number of research reports. Shore Capital Group reissued a “house stock” rating on shares of Judges Scientific in a report on Thursday, July 23rd. Berenberg Bank reiterated a “buy” rating and set a GBX 5,600 price target on shares of Judges Scientific in a research note on Wednesday. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, Judges Scientific presently has a consensus rating of “Buy” and an average price target of GBX 6,490.

Get Our Latest Analysis on JDG

Insider Buying and Selling

In other news, insider Ralph Elman acquired 122 shares of the firm’s stock in a transaction dated Friday, July 17th. The shares were purchased at an average cost of GBX 4,917 per share, for a total transaction of £5,998.74. Also, insider Bradley Leonard Ormsby bought 63 shares of the stock in a transaction that occurred on Friday, July 17th. The shares were purchased at an average price of GBX 4,917 per share, for a total transaction of £3,097.71. 9.92% of the stock is currently owned by company insiders.

About Judges Scientific

(Get Free Report)

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen’s Awards for innovation and export.

The Group’s companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.